Cargando…
The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
Vaccinations with the 10-valent pneumococcal conjugated vaccine (PHiD-CV) started in Iceland in 2011. Protein D (PD) from H. influenzae, which is coded for by the hpd gene, is used as a conjugate in the vaccine and may provide protection against PD-positive H. influenzae. We aimed to evaluate the ef...
Autores principales: | Sveinsdóttir, Hildigunnur, Björnsdóttir, Jana Birta, Erlendsdóttir, Helga, Hjálmarsdóttir, Martha Á., Hrafnkelsson, Birgir, Haraldsson, Ásgeir, Kristinsson, Karl G., Haraldsson, Gunnsteinn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595461/ https://www.ncbi.nlm.nih.gov/pubmed/31068412 http://dx.doi.org/10.1128/JCM.00116-19 |
Ejemplares similares
-
Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland
por: Quirk, Sigríður J., et al.
Publicado: (2019) -
Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland
por: Hjálmarsdóttir, Martha Á., et al.
Publicado: (2020) -
The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland—A population-based time series analysis
por: Eythorsson, Elias, et al.
Publicado: (2021) -
Impact of the 10-valent pneumococcal conjugate vaccine on antimicrobial prescriptions in young children: a whole population study
por: Eythorsson, Elias, et al.
Publicado: (2018) -
Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland
por: Hjálmarsdóttir, Martha Á., et al.
Publicado: (2017)